Leap Therapeutics
LPTX
LPTX
59 hedge funds and large institutions have $14.7M invested in Leap Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
3% less funds holding
Funds holding: 61 → 59 (-2)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Holders
59
Holding in Top 10
–
Calls
$7K
Puts
$2K
Top Buyers
| 1 | +$2.33M | |
| 2 | +$523K | |
| 3 | +$504K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$412K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$357K |
Top Sellers
| 1 | -$521K | |
| 2 | -$362K | |
| 3 | -$345K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$208K |
| 5 |
Renaissance Technologies
New York
|
-$160K |